Thursdays regulatory victory is backed by data from the Phase IIb HERIZON-BTC-01 study, which reported a 41.3% confirmed objective response rate in patients treated with Ziihera, with treatment response lasting for a median of 12.9 months
Get the reconstitution wrong and your carefully purchased compound degrades before you can use half the vial
However, investors may be concerned about the company's likelihood of bringing this drug to market quickly enough to capture a sizable customer base, given that many alternatives are already available or are rushing through development
However, eligibility criteria may vary, and a healthcare professional can assess whether this medication is appropriate for a specific individual
The wavelength is about 200 nm, or about 205 nm, or about 210 nm, or about 215 nm, or about 220 nm, or about 225 nm, or about 230 nm, or about 235 nm, or about 240 nm, or about 245 nm or about 250 nm
The side effects look familiar in many ways, especially gastrointestinal symptoms, but there are also a few signalslike changes in heart ratethat researchers are still watching closely